C-reactive protein and disease activity in children with Crohn's disease

Digestive Diseases and Sciences

Volumn 55, Issue 1, 2010, Pages 131-136

  Tilakaratne, Samantha ^a   Lemberg, Daniel A ^a,b   Leach, Steven T ^b   Day, Andrew S ^a  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

C reactive protein; Children; Crohn's disease; Disease activity

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERIC FEEDING; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; BLOOD; INFANT; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; HUMANS; INFANT; MALE; SENSITIVITY AND SPECIFICITY;

EID: 74049141166     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1017-8     Document Type: Article

References (23)

1. S Vermeire G Van Assche P Rutgeerts 2004 C-reactive protein as a marker for inflammatory bowel disease Inflamm Bowel Dis 10 661 665 10.1097/00054725- 200409000-00026 15472532 (Pubitemid 39276479)
2. CA Solem EV Loftus Jr WJ Tremaine WS Harmsen AR Zinsmeister WJ Sandborn 2005 Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease Inflamm Bowel Dis 11 707 712 10.1097/01.MIB.0000173271.18319.53 16043984 (Pubitemid 41271173)
3. JS Hyams GD Ferry FS Mandel, et al. 1991 Development and validation of a pediatric Crohn's disease activity index J Pediatr Gastroenterol Nutr 12 439 447 1:STN:280:DyaK3MzisV2qtA%3D%3D 1678008
4. AM Griffiths AR Otley J Hyams, et al. 2005 A review of activity indices and end points for clinical trials in children with Crohn's disease Inflamm Bowel Dis 11 185 196 10.1097/00054725-200502000-00013 15677913 (Pubitemid 40711224)
5. J Hyams J Markowitz A Otley, et al. 2005 Evaluation of the pediatric Crohn's disease activity index: a prospective multicenter experience J Pediatr Gastroenterol Nutr 41 416 421 10.1097/01.mpg.0000183350.46795.42 16205508 (Pubitemid 41407602)
6. MS Silverberg J Satsangi T Ahmad, et al. 2005 Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 5 36 16151544
7. M Boirivant M Leoni D Tariciotti S Fais O Squarcia F Pallone 1988 The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study J Clin Gastroenterol 10 401 405 10.1097/00004836-198808000-00011 1:STN:280:DyaL1czjtFOluw%3D%3D 3418087
8. C Cellier T Sahmoud E Froguel, et al. 1994 Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives Gut 35 231 235 10.1136/gut.35.2.231 1:STN:280:DyaK2c7ktVaguw%3D%3D 7508411
9. P Chamouard Z Richert N Meyer G Rahmi R Baumann 2006 Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease Clin Gastroenterol Hepatol 4 882 887 10.1016/j.cgh.2006.02.003 1:CAS:528: DC%2BD28XotFarsrc%3D 16630759 (Pubitemid 43994532)
10. D Desai WA Faubion WJ Sandborn 2007 Review article: biological activity markers in inflammatory bowel disease Aliment Pharmacol Ther 25 247 255 1:CAS:528:DC%2BD2sXjtlelsbk%3D 17217454
11. EA Fagan RF Dyck PN Maton, et al. 1982 Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis Eur J Clin Invest 12 351 359 10.1111/j.1365-2362.1982.tb02244.x 1:STN:280:DyaL3s%2FltlCksQ%3D%3D 6814926
12. L Filik U Dagli A Ulker 2006 C-reactive protein and monitoring the activity of Crohn's disease Adv Ther 23 655 662 10.1007/BF02850054 1:CAS:528:DC%2BD28Xht12htrrJ 17050508
13. S Karoui S Ouerdiane M Serghini, et al. 2007 Correlation between levels of C-reactive protein and clinical activity in Crohn's disease Dig Liver Dis 39 1006 1010 10.1016/j.dld.2007.06.015 1:CAS:528:DC%2BD1cXht1eitr4%3D 17889628 (Pubitemid 350018697)
14. J Langhorst S Elsenbruch J Koelzer A Rueffer A Michalsen GJ Dobos 2008 Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices Am J Gastroenterol 103 162 169 17916108
15. S Vermeire G Van Assche P Rutgeerts 2006 Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55 426 431 10.1136/gut.2005.069476 1:STN:280:DC%2BD28%2Fos1ejsA%3D%3D 16474109 (Pubitemid 43268284)
16. AD Rodgers AG Cummins 2007 CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease Dig Dis Sci 52 2063 2068 10.1007/s10620-006-9691-2 17436102 (Pubitemid 47246515)
17. PI Macfarlane V Miller F Wells B Richards 1986 Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis J Pediatr Gastroenterol Nutr 5 93 96 1:STN:280:DyaL287hsVKjsw%3D%3D 3944748
18. JF Colombel CA Solem WJ Sandborn, et al. 2006 Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein Gut 55 1561 1567 10.1136/gut.2005.084301 1:CAS:528:DC%2BD28Xht1GkurvP 16648154 (Pubitemid 44629202)
19. M-A Denis C Reenaers F Fontaine J Belaiche E Louis 2007 Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level Inflamm Bowel Dis 13 1100 1105 10.1002/ibd.20178 17508418 (Pubitemid 47402593)
20. THJ Florin EWJ Paterson EV Fowler GL Radford-Smith 2006 Clinically active Crohn's disease in the presence of a low C-reactive protein Scand J Gastroenterol 41 306 311 10.1080/00365520500217118 1:CAS:528: DC%2BD28Xhslektrs%3D 16497618 (Pubitemid 43311042)
21. AS Day KE Whitten DA Lemberg, et al. 2006 Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach J Gastroenterol Hepatol 21 1609 1614 10.1111/j.1440-1746.2006.04294.x 16928225 (Pubitemid 44266523)
22. NS de Jong ST Leach AS Day 2006 Fecal S100A12: a novel noninvasive marker in children with Crohn's disease Inflamm Bowel Dis 12 566 572 10.1097/01.ibd.0000227626.72271.91 16804393 (Pubitemid 43977737)
23. MA Sidler ST Leach AS Day 2008 Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children Inflamm Bowel Dis 14 359 366 10.1002/ibd.20336 18050298